๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

โœ Scribed by Sabino De Placido; Chiara Carlomagno; Michelino De Laurentiis; AngeloRaffaele Bianco

Book ID
110232660
Publisher
Springer US
Year
1998
Tongue
English
Weight
639 KB
Volume
52
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic value of c-erbB2 expression i
Prognostic value of c-erbB2 expression in breast cancer
โœ Shinichi Tsutsui; Shinji Ohno; Shigeru Murakami; Yoichi Hachitanda; Shinya Oda ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 1 views
Downregulation of erbB3 abrogates erbB2-
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
โœ Bolin Liu; Dalia Ordonez-Ercan; Zeying Fan; Susan M. Edgerton; XiaoHe Yang; Ann ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 654 KB

## Abstract Receptor tyrosine kinase activity is essential for erbB2 (HER2/__neu__) promotion of breast carcinogenesis, metastasis and therapeutic resistance. erbB2 kinase can be activated by dimerization with another erbB receptor, most of which bind ligands. Of these, the erbB2/erbB3 heterodimer